Background: Results of previous clinical trials evaluating the effect of magnesium
supplementation on inflammatory markers are controversial. Objective: A systematic review …

Statin intolerance is the inability to tolerate a dose of statin required to sufficiently reduce
cardiovascular (CV) risk. 1 This limits the effective treatment of patients at risk of, or with, CV …

Guidelines The Guidelines have been officially approved and supported by the Polish
Society of Family Medicine (PSFM). With the consent of Authors and Editorial Boards of …

Statins reduce cardiovascular morbidity and mortality in primary and secondary prevention.
Despite their efficacy, many persons are unable to tolerate statins due to adverse events …

An extensive evaluation of disease occurrence after statin use based on a “hypothesis-free”
approach remains scarce. To examine the effect of statin use on the potential risk of …

Background Recent studies have highlighted the possible risk of neuropsychiatric adverse
effects during treatment with lipid-lowering medications. However, there are still …

Background Systemic inflammation is a significant mechanism underpinning adverse
cognitive changes. Sleep quality is a crucial factor associated with systemic inflammation …

Aims: To investigate the impact of thinning at individual grids of macular neuroretinal layers,
clinical factors, and inadequate light exposure on the specific components of sleep disorder …

Study design DYSIS II was a multicountry, multicenter observational study of patients with
stable CHD and patients surviving any ACS event. Greece was one of 7 European countries …

Objective Psychiatric hospitalizations and emergency department (ED) visits are costly,
stigmatizing, and often ineffective. Given the immune and kynurenine activation in bipolar …